MiNK Therapeutics Reports Second Quarter 2023 Results

Go back to MiNK Therapeutics Reports Second Quarter 2023 Results
(NASDAQ: INKT) Delayed: 11.41 +0.28 (2.52%)
Previous Close $11.13    52 Week High
Open $11.10    52 Week Low
Day High $11.41    P/E N/A 
Day Low $10.98    EPS
Volume 2,227